Experience with the Guthrie test in Scotland is reviewed. The test continues to be inexpensive and reliable for the detection of PKU in neonates. It is possibleto use the specimen obtained for the test to screenfor a varietyof additional disorderswith minimaladdition of cost and effort.
average around the tenth day of life, from every neonate, it is possible to use the remaining blood to screen for other inborn errors of metabolism. The conditions for which we have so far been able to screen, all have a much lower incidence than PKU. However the cost of adding these new tests to the programme is very low. These extensions of the screening programme for inborn errors of metabolism from the dried blood spot-not all of which are inhibition assays-are dealt with not by order of importance, but rather as they have evolved.
In theory it is possible to assay levels of any amino acid in blood or urine provided there is a suitable inhibitor and organism. The following assays are now in routine use:
Methionine To date 190000 neonates have been screened. No cases of homocystinuria have been detected but there have been several cases of persistent methionaernia. Most of these cases have been associated with a primary liver disorder, but two appear to have no recognisable cause.
Leucine. In disorders of the branched chain amino acids, leucine generally shows a higher elevation than isoleucine or valine.
To date 180000 neonates have been screened. One probable case of maple syrup urine disease has been detected. The initial blood leucine concentration exceeded 80 mg/l00 ml, The child died and the pathology report is awaited.
Tyrosine. Although only a few cases of primary block in the metabolism of tyrosine have been described, the occurrence of transient tyrosinaernia is well recognised though its implication is not yet clear. Approximately 110000 neonates have been screened for raised levels of tyrosine, 600 have shown elevations in excess of 20 mg/l00 mI. Of these 50% have been associated with elevations of blood phenylalanine. A few have occurred in association with elevated blood methionine. This incidence is much greater than that encountered by those using on the test in the U.S.A. and elsewhere. We do not as 115
In contemplating mass screening for any inborn error of metabolism, there are two main considerations; 1. The frequency of the disorder and 2. The cost of the test. During the past decade, programmes for screening for phenylketonuria have been initiated in numerous centres throughout the world. While not the most common of inborn errors of metabolism, PKU has a relatively high incidence and there is some hope that treatment will prevent the unfortunate consequences of the disorder. This latter factor is an important consideration in the setting up of routine screening programmes within the framework of the National Health Service. Because of its simplicity, reliability and low cost, the bacterial inhibition assay as described by Guthrie and Susi (1963) is the method most extensively used at present and recommended by the Department of Health for use in routine screening programmes.
The principle of the inhibition assay is that growth of Bacillus subtilis, ATCC 6051 in a minimal culture medium is inhibited by B 2 thienylalanine. This inhibition of growth is prevented by phenylalanine; the amount of growth occurring being directly proportional to the amount of phenylalanine present.
Specimens are obtained on a piece of thick, very absorbent, filter paper of known quality. A disc, of known diameter, is punched from this paper. Together with a series of control discs, of equal diameter, containing known amounts of phenylalanine, it is placed on the surface of an agar culture medium containing B.subtilis spores and B 2-thienylalanine in known concentration. After overnight incubation the concentration of phenylalanine is obtained by comparing the diameter of growth around the test discs with the growth around the control discs.
The Guthrie test has been used to screen for PKU in Scotland since 1965. During this period 435000 neonates have been screened resulting in the detection of 54 cases of PKU, six cases of atypical or mild PKU, subsequently placed on diet, and nine cases of persistent hyperphenylalanaernia, which do not require dietary treatment. This incidence, we feel, justifies the cost of the screening programme.
Having obtained blood specimens, taken 
Thin layer chromatography
This can be performed on eluates from a dried blood spot. So far we have not used this for screening.
troph type have been proposed are ortodylic aciduria, hereditary angioneurotic oedema, glucose-ti-phosphate dehydrogenase deficiency,glutathione reductase deficiency and (XI-antitrypsin deficiency. None of these are as yet used for screening.
Enzyme 'auxotroph' tests.
The principle of this test is similar to that of the Beutler test in that the substrate of the enzyme in question is incubated with the blood spot. Where the enzyme is present a product is formed. Whereas in the Beutler test the presence of the product is detected by fluorescence, in the auxotroph test its presence is shown by the growth of an organism for which the product is an essential growth factor. One such test is routinely used in some centres to detect arginosuccinic aciduria, a very rare condition. Other conditions for which tests of the Beutler or auxo-yet know the reason for this. It is possible that the timing of the test-taken on the fourth day of life in the U.S.A. as against tenth-fourteenth day of life in Scotland may account for this. However the type of feeding or some other unknown factor cannot be discounted. Investigation of these cases is to some extent limited by the number of repeat tests required. Where this is high, co-operation from those taking the specimens is endangered and this must be borne in mind when adding any test, or group of tests, to a screening programme.
Histidine. Screening for elevated levels of histidine is now a routine procedure in centres in U.S.A., New Zealand and Austria.
Screening for galactosaemia
Two tests are available for mass screening for galactosaemia.
In the E. coli test for levels of blood galactose (Guthrie, 1968 ) blood discs are placed on an agar medium containing a mutant E. coli which is itself deficient in galactose-I-phosphate uridyl transferase. Where galactose is present in the blood the disc is surrounded by a zone of inhibition. The amount of galactose present is obtained by comparing the diameter of the zone of inhibition with those of a series of control discs.
The test of Beutler and Baluda (1966) detects the presence or absence of the transferase enzyme. Both tests have features for and against them. 1. Since the E. coli test measures blood galactose it is possible to detect cases of galactokinase deficiency as well as transferase deficiency. 2. The E. coli test is less expensive than the Beutler test. 3. The Beutler test is simpler to perform. 4. The Beutler test could be performed at an earlier age than the E. coli test and is independent of diet. It should be possible to detect cases of galactosaemia before they become clinically evident. The incidence of galactosaemia appears to be about 1 in 100000. Galaetokinase deficiency is approximately 1 in 700000.
